What we cover: The biology of ageing, the research behind longevity interventions, epigenetics, metabolic health, and the gap between what the science says and what the market sells.
Biological age and chronological age diverge more than most people realise by midlife. The gap is largely driven by five modifiable factors.
Epigenetic clocks have revealed that two people of the same age can have biological ages years apart. The determinants are largely within our control.
The longevity supplement market is worth billions. The lifestyle inputs with the strongest evidence cost almost nothing. That gap is worth understanding.
Blue Zones research and caloric restriction studies both point in the same direction. So why does the industry keep pointing elsewhere?
The longevity biomarkers worth tracking — and the ones that aren't
VO₂ max, HOMA-IR, ApoB, Lp(a) — which markers actually predict healthspan, and how to interpret them without a research background.